Evidence map›Paper›PMID 36079372›Full record

ArticleMaterials (Basel, Switzerland)2022

Characterizations of Alpha-Cellulose and Microcrystalline Cellulose Isolated from Cocoa Pod Husk as a Potential Pharmaceutical Excipient.

Olutayo A Adeleye, Oluyemisi A Bamiro, Doha A Albalawi, Amenah S Alotaibi, Haroon Iqbal, Saheed Sanyaolu, Mbang N Femi-Oyewo, Kehinde O Sodeinde, Zwanden S Yahaya, Gobika Thiripuranathar and 1 more

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Olutayo A AdeleyeDepartment of Pharmaceutics and Pharmaceutical Technology, Federal University Oye-Ekiti, Oye-Ekiti 3600001, Ekiti State, Nigeria.ORCID 0000-0001-8716-4064
Oluyemisi A BamiroDepartment of Pharmaceutics and Pharmaceutical Technology, Olabisi Onabanjo University, Ago-Iwoye 120107, Ogun State, Nigeria.
Doha A AlbalawiDepartment of Biology, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.
Amenah S AlotaibiGenomic & Biotechnology Unit, Department of Biology, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.
Haroon IqbalThe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, China.ORCID 0000-0002-7908-8804
Saheed SanyaoluDepartment of Pharmaceutics and Pharmaceutical Technology, Olabisi Onabanjo University, Ago-Iwoye 120107, Ogun State, Nigeria.
Mbang N Femi-OyewoDepartment of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, Afe Babalola University, Ado-Ekiti 360101, Ekiti State, Nigeria.
Kehinde O SodeindeDepartment of Industrial Chemistry, Federal University Oye-Ekiti, Oye-Ekiti 3600001, Ekiti State, Nigeria.
Zwanden S YahayaDepartment of Pharmaceutics and Industrial Pharmacy, Kaduna State University, Kabala Coastain 800283, Kaduna State, Nigeria.
Gobika ThiripuranatharInstitute of Chemistry Ceylon, College of Chemical Sciences, Rajagiriya 10107, Sri Lanka.ORCID 0000-0002-0904-9519
Farid MenaaDepartment of Pharmaceutics and Nanomedicine, Fluorotronics Inc. and California Innovations Corp., San Diego, CA 92037, USA.ORCID 0000-0002-0258-7322
Afe Babalola University · NGOlabisi Onabanjo University · NGUniversity of Tabuk · SAFederal University Oye Ekiti · NGFluor (United States) · USKaduna State University · NGZhejiang Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellulose is a non-toxic, bio-degradable, and renewable biopolymer which is abundantly available in nature. The most common source of commercial microcrystalline cellulose is fibrous wood pulp. Cellulose and its derivatives have found wide commercial applications in the pharmaceutical, cosmetic, food, paper, textile, and engineering industries. This study aims to isolate and characterize cellulose forms from cocoa pod husk (CPH) and to assess its mechanical and disintegration properties as a direct compression excipient in metronidazole tablets. Two isolated cellulose types (i.e., cocoa alpha-cellulose (CAC) and cocoa microcrystalline cellulose (C-MCC)) were compared with avicel (AV). CAC and C-MCC were characterized for their physicochemical properties using Scanning Electron Microscopy (SEM), FTIR spectroscopy, Differential Scanning Calorimetry (DSC), and X-Ray Powder Diffraction (XRD). Metronidazole tablets were produced by direct compression with cellulose. The mechanical and disintegration properties of the tablets were evaluated. CAC and C-MCC yield was 42.3% w/w and 38.25% w/w, respectively. Particle diameters were significantly different with CAC (282.22 μm) > C-MCC (161.32 μm) > AV (72.51 μm). CAC and C-MCC had a better flow than AV. SEM revealed the fibrous nature of the cellulose. FTIR and XRD analysis confirmed the presence of cellulose with crystallinity index of 69.26%, 43.83%, and 26.32% for AV, C-MCC, and CAC, respectively. C-MCC and AV are more crystalline and thermally stable at high temperatures compared to CAC. The mechanical and disintegration properties of C-MCC and AV tablets complied with pharmacopeia specifications. Taken together, C-MCC isolated from CPH displayed some fundamental characteristics suitable for use as a pharmaceutical excipient and displayed better properties compared to that of AV.

Indexed as

alpha cellulosecocoa pod huskdirect compressionmetronidazole tabletmicrocrystalline cellulose

Identifiers

PMID36079372
PMCPMC9457090
OpenAlexW4293773750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.